Long COVID: Recovery Challenges Persist 😷
In treating
#LongCOVID, David Putrino from Mount Sinai Health System has seen diverse patient outcomes. A small percentage still struggles with unrelenting symptoms, while some show progress but remain sick. A cautious optimism surrounds the 15-20% fully recovered group. However, Putrino highlights the recurring nature of symptoms, making full recovery complex.
With 200 symptoms linked to Long COVID, understanding recovery rates remains an ongoing challenge. Recent CDC data shows a 6% prevalence among adults, down from 7.5%. A year post-infection, symptoms tend to recede, especially after mild cases. Yet, Nature Medicine’s study suggests persistent risks even after two years, impacting over 20 symptoms. Research differences stem from design nuances and recovery definitions.
NIH trials explore treatment options, but individualized approaches are essential due to symptom variations. Each patient’s unique profile guides therapies, from supplements to nerve stimulation. The rarity of full recovery emphasizes the need for extensive treatment trials to address this evolving health crisis.
#LongCOVID #HealthResearch #RecoveryChallenges 💪🏥🦠
time.com/6309054/long-covid-…